@article{3120077,
    title = "Oral ribavirin is a highly effective treatment for lower respiratory tract infections due to respiratory syncytial virus or parainfluenza after allogeneic stem cell transplantation",
    author = "Stamouli, M. and Tsonis, I. and Gkirkas, K. and Economopoulou, C. and Siafakas, N. and Pournaras, S. and Antoniadou, A. and Chondropoulos, S. and Karagiannidi, A. and Meletiadis, J. and Gigantes, S. and Baltadakis, I. and Goussetis, E. and Karakasis, D. and Tsirigotis, P.",
    journal = "Bone marrow transplantation. Supplement (Basingstoke)",
    year = "2021",
    volume = "56",
    number = "2",
    pages = "511-513",
    publisher = "Springer Nature BV",
    doi = "10.1038/s41409-020-01022-x",
    keywords = "immunoglobulin G;  prednisolone;  ribavirin, adolescent;  adult;  aged;  allogeneic stem cell transplantation;  arterial wall thickening;  artificial ventilation;  bronchiolitis obliterans;  bronchiolitis obliterans organizing pneumonia;  bronchoscopy;  child;  clinical article;  computer assisted tomography;  coughing;  creatinine clearance;  disease severity;  dyspnea;  female;  fever;  ground glass opacity;  human;  hypoxemia;  infant;  Letter;  lower respiratory tract infection;  lung lavage;  lung nodule;  lymphocyte count;  male;  multiplex polymerase chain reaction;  Parainfluenza virus infection;  priority journal;  relapse;  respiratory distress;  respiratory failure;  respiratory syncytial virus infection;  respiratory tract intubation;  treatment response"
}